AI Medical Device Company Aillis Selected for Tokyo's "SusHi Tech Global" Growth Acceleration Program, Phase 1
NQ Score
100/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Japanese innovative medical AI technology accelerates global scale-up.
AI Analysis
Frequently Asked Questions
- Q: What is the "SusHi Tech Global Growth Acceleration Program"?
- A: It is a startup support program promoted by the Tokyo Metropolitan Government, providing funding and tailored hands-on support to companies aiming for exponential global growth.
- Q: What kind of company is Aillis Inc.?
- A: Founded in 2017, Aillis is an AI medical device development company where active doctors and AI specialists utilize deep learning technology to digitize doctors' expert skills into medical devices.
- Q: What benefits will Aillis gain from this selection?
- A: Aillis will receive up to 200 million yen in funding support for up to 18 months, tailored hands-on support covering business strategy to overseas travel, and access to specialized knowledge and a global network in AI and healthcare.